A citation-based method for searching scientific literature

J P Pin, R Duvoisin. Neuropharmacology 1995
Times Cited: 1949







List of co-cited articles
957 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Colleen M Niswender, P Jeffrey Conn. Annu Rev Pharmacol Toxicol 2010
29

Pharmacology and functions of metabotropic glutamate receptors.
P J Conn, J P Pin. Annu Rev Pharmacol Toxicol 1997
25

Metabotropic glutamate receptors: from the workbench to the bedside.
F Nicoletti, J Bockaert, G L Collingridge, P J Conn, F Ferraguti, D D Schoepp, J T Wroblewski, J P Pin. Neuropharmacology 2011
398
21


Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain.
R Shigemoto, S Nomura, H Ohishi, H Sugihara, S Nakanishi, N Mizuno. Neurosci Lett 1993
446
11

Metabotropic glutamate receptors as novel targets for anxiety and stress disorders.
Chad J Swanson, Mark Bures, Michael P Johnson, Anni-Maija Linden, James A Monn, Darryle D Schoepp. Nat Rev Drug Discov 2005
457
10

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.
Sandeep T Patil, Lu Zhang, Ferenc Martenyi, Stephen L Lowe, Kimberley A Jackson, Boris V Andreev, Alla S Avedisova, Leonid M Bardenstein, Issak Y Gurovich, Margarita A Morozova,[...]. Nat Med 2007
779
8

Glutamate receptor ion channels: structure, regulation, and function.
Stephen F Traynelis, Lonnie P Wollmuth, Chris J McBain, Frank S Menniti, Katie M Vance, Kevin K Ogden, Kasper B Hansen, Hongjie Yuan, Scott J Myers, Ray Dingledine. Pharmacol Rev 2010
8

Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus.
R Shigemoto, A Kinoshita, E Wada, S Nomura, H Ohishi, M Takada, P J Flor, A Neki, T Abe, S Nakanishi,[...]. J Neurosci 1997
842
8


Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain.
C Romano, M A Sesma, C T McDonald, K O'Malley, A N Van den Pol, J W Olney. J Comp Neurol 1995
559
8


Correction of fragile X syndrome in mice.
Gül Dölen, Emily Osterweil, B S Shankaranarayana Rao, Gordon B Smith, Benjamin D Auerbach, Sumantra Chattarji, Mark F Bear. Neuron 2007
679
8

Cloned glutamate receptors.
M Hollmann, S Heinemann. Annu Rev Neurosci 1994
8


Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Kimberly M Huber, Sean M Gallagher, Stephen T Warren, Mark F Bear. Proc Natl Acad Sci U S A 2002
950
7


Metabotropic glutamate receptors.
Francesco Ferraguti, Ryuichi Shigemoto. Cell Tissue Res 2006
352
7

The glutamate receptor ion channels.
R Dingledine, K Borges, D Bowie, S F Traynelis. Pharmacol Rev 1999
7

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
Daniella Rylander, Hanna Iderberg, Qin Li, Andrzej Dekundy, Jinlan Zhang, Hao Li, Ren Baishen, Wojciech Danysz, Erwan Bezard, M Angela Cenci. Neurobiol Dis 2010
124
7


A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
François Tison, Charlotte Keywood, Mark Wakefield, Franck Durif, Jean-Christophe Corvol, Karla Eggert, Mark Lew, Stuart Isaacson, Erwan Bezard, Sonia-Maria Poli,[...]. Mov Disord 2016
75
9

Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms.
Clare M Gladding, Stephen M Fitzjohn, Elek Molnár. Pharmacol Rev 2009
145
7


Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder.
Eduardo Dunayevich, Janelle Erickson, Louise Levine, Ronald Landbloom, Darryle D Schoepp, Gary D Tollefson. Neuropsychopharmacology 2008
146
6

AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
Fabrizio Stocchi, Olivier Rascol, Alain Destee, Nobutaka Hattori, Robert A Hauser, Anthony E Lang, Werner Poewe, Mark Stacy, Eduardo Tolosa, Haitao Gao,[...]. Mov Disord 2013
98
6

The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.
Corrado Corti, Giuseppe Battaglia, Gemma Molinaro, Barbara Riozzi, Anna Pittaluga, Mauro Corsi, Manolo Mugnaini, Ferdinando Nicoletti, Valeria Bruno. J Neurosci 2007
158
6



Glutamate receptors as therapeutic targets for Parkinson's disease.
Kari A Johnson, P Jeffrey Conn, Colleen M Niswender. CNS Neurol Disord Drug Targets 2009
149
6


The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model.
Erwan Bezard, Elsa Y Pioli, Qin Li, Françoise Girard, Vincent Mutel, Charlotte Keywood, Francois Tison, Olivier Rascol, Sonia M Poli. Mov Disord 2014
45
13

The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeys.
Laurent Grégoire, Nicolas Morin, Bazoumana Ouattara, Fabrizio Gasparini, Graeme Bilbe, Donald Johns, Ivo Vranesic, Srikumar Sahasranaman, Baltazar Gomez-Mancilla, Thérèse Di Paolo. Parkinsonism Relat Disord 2011
74
8

Native group-III metabotropic glutamate receptors are coupled to the mitogen-activated protein kinase/phosphatidylinositol-3-kinase pathways.
L Iacovelli, V Bruno, L Salvatore, D Melchiorri, R Gradini, A Caricasole, E Barletta, A De Blasi, F Nicoletti. J Neurochem 2002
95
6


Metabotropic glutamate receptors: phosphorylation and receptor signaling.
Chul Hoon Kim, Jinu Lee, Jae-Youn Lee, Katherine W Roche. J Neurosci Res 2008
90
6

Constitutive internalization and recycling of metabotropic glutamate receptor 5 (mGluR5).
Rishi Raj Trivedi, Samarjit Bhattacharyya. Biochem Biophys Res Commun 2012
28
21


A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors.
Etienne Doumazane, Pauline Scholler, Jurriaan M Zwier, Eric Trinquet, Philippe Rondard, Jean-Philippe Pin. FASEB J 2011
194
6

Development of allosteric modulators of GPCRs for treatment of CNS disorders.
Hilary Highfield Nickols, P Jeffrey Conn. Neurobiol Dis 2014
143
6

The mGluR theory of fragile X mental retardation.
Mark F Bear, Kimberly M Huber, Stephen T Warren. Trends Neurosci 2004
6

Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells.
Nuria Cabello, Jorge Gandía, Daniela C G Bertarelli, Masahiko Watanabe, Carme Lluís, Rafael Franco, Sergi Ferré, Rafael Luján, Francisco Ciruela. J Neurochem 2009
197
6

Metabotropic glutamate receptors and neurodegenerative diseases.
Fabiola M Ribeiro, Luciene B Vieira, Rita G W Pires, Roenick P Olmo, Stephen S G Ferguson. Pharmacol Res 2017
98
6

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors.
A E Kingston, P L Ornstein, R A Wright, B G Johnson, N G Mayne, J P Burnett, R Belagaje, S Wu, D D Schoepp. Neuropharmacology 1998
311
5




A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo.
Kayo Mitsukawa, Rina Yamamoto, Silvio Ofner, Joachim Nozulak, Oliver Pescott, Snezana Lukic, Natacha Stoehr, Cedric Mombereau, Rainer Kuhn, Kevin H McAllister,[...]. Proc Natl Acad Sci U S A 2005
195
5


Group III and subtype 4 metabotropic glutamate receptor agonists: discovery and pathophysiological applications in Parkinson's disease.
M Amalric, S Lopez, C Goudet, G Fisone, G Battaglia, F Nicoletti, J-P Pin, F C Acher. Neuropharmacology 2013
44
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.